FIELD: biochemistry.
SUBSTANCE: invention relates to the field of biochemistry, in particular to an isolated antibody, which specifically binds to human LAG3. Nucleic acid encoding the specified antibody, a host cell containing the specified nucleic acid, and a pharmaceutical composition containing the specified antibody are also disclosed. A method for the production of the specified antibody, and the use of the specified antibody for the treatment of diseases associated with human LAG3 are disclosed.
EFFECT: invention allows for the effective treatment of cancer associated with human LAG3.
9 cl, 3 ex, 3 tbl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO PD1 AND LAG3 | 2018 |
|
RU2778805C2 |
| ANTI-HLA-G ANTIBODIES AND THEIR USE | 2019 |
|
RU2797724C2 |
| PD1 ANTIBODIES AND THEIR APPLICATION METHODS | 2016 |
|
RU2746409C1 |
| ANTIBODIES AGAINST SIGNAL-REGULATORY ALPHA PROTEIN AND THEIR APPLICATION METHODS | 2017 |
|
RU2771964C2 |
| ANTI-TIM3 ANTIBODIES AND METHODS FOR USING THEM | 2015 |
|
RU2723708C2 |
| ANTIBODIES TO DENGUE VIRUS, POLYPEPTIDES CONTAINING FC-REGION OPTIONS AND THEIR APPLICATION METHODS | 2017 |
|
RU2758596C2 |
| ANTIBODIES TO DENGUE VIRUS WITH CROSS-REACTIVITY WITH ZIKA VIRUS | 2019 |
|
RU2811697C2 |
| ANTI-TAU PROTEIN ANTIBODIES AND METHODS OF USING SAID ANTIBODIES | 2016 |
|
RU2732122C2 |
| C5 ANTIBODIES AND THEIR APPLICATION METHODS | 2015 |
|
RU2746356C2 |
| ANTI-C5 ANTIBODIES AND METHODS FOR THEIR USE | 2017 |
|
RU2789788C2 |
